Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran

Cost-effectiveness and cost–utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran

Objective: Gastrointestinal bleeding, a side effect of clopidogrel, is usually prevented by proton-pump inhibitors (PPIs). Due to omeprazole's inhibitory effects on the liver enzyme CYP2C19, its concomitant use with clopidogrel is argued to increase the risk of myocardial infarction (MI) recurr...

Full description

Bibliographic Details
Main Authors:	Mohammadreza Amirsadri, Valiollah Hajhashemi, Amir Shahriar Asemi
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Journal of Research in Pharmacy Practice
Subjects:	clopidogrel cost-effectiveness cost–utility myocardial infarction omeprazole pantoprazole
Online Access:	http://www.jrpp.net/article.asp?issn=2319-9644;year=2021;volume=10;issue=2;spage=90;epage=95;aulast=

Similar Items

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática Clinical relevance of clopidogrel and omeprazole interaction: systematic review
by: Héctor Holguín, et al.
Published: (2012-01-01)

Omeprazol y clopidogrel asociado a trombosis de stent
by: Ricardo Amador García Hernández, et al.

Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report
by: Isabel J. B. van der Zalm, et al.
Published: (2020-06-01)

Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
by: Dolores Ochoa, et al.
Published: (2020-07-01)

Relevancia clínica de la interacción clopidogrel y omeprazol: revisión sistemática
by: Héctor Holguín, QF, et al.
Published: (2012-01-01)

Platelets prohibition with clopidogrel alone versus with proton-pump inhibitors
by: Feryal Hashim Rada
Published: (2021-01-01)

Comparison of the Effect of Omeprazole, Pantoprazole, Esomeprazole, and Lansoprazole on the Reduction of Symptoms in Patients with Gastroesophageal Reflux Disease
by: Nima Arezoomandi, et al.
Published: (2019-02-01)

Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
by: Kenngott S, et al.
Published: (2010-05-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01)

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01)

Pilot experience with clopidogrel in the treatment of an .ST-elevation acute myocardial infarction
by: S V Shalaev, et al.
Published: (2004-06-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Acute Hypersensitivity Reaction Related to use of Pantoprazole Lacking Cross-Reactivity with Omeprazole
by: Hemangini Rajanikant Acharya, et al.
Published: (2018-06-01)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Karla N. Samman, et al.
Published: (2021-06-01)

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01)

Rare but possible: clopidogrel-induced pancytopenia
by: Pietro Bocchi, et al.
Published: (2023-10-01)

Supplementation of Lipoic Acid, Zinc and Clopidogrel Reduces Mortality Rate and Incidence of Ventricular Arrhythmia in Experimental Myocardial Infarction
by: Enas Abdel-Hady, et al.
Published: (2021-03-01)

Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study
by: Salman Nikfarjam, et al.
Published: (2023-01-01)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
by: Amir Hashemi-meshkini, et al.
Published: (2023-04-01)

Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
by: Anke C. Fender, et al.
Published: (2020-04-01)

The effectiveness and cost of lansoprazole and pantoprazole for stress ulcer prophylaxis in intensive care unit
by: Mega Octavia, et al.
Published: (2021-11-01)

Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis
by: Matteo Vercellino, et al.
Published: (2017-04-01)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
by: Algra Ale, et al.
Published: (2000-11-01)

The Utilization Evaluation of Intravenous Pantoprazole for Stress Ulcer Prophylaxis in a Major Teaching Hospital
by: Shahriyar Shahbazi Khamas, et al.
Published: (2022-10-01)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
by: Vojko Kanic, et al.
Published: (2024-01-01)

A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital
by: A. Avinash, et al.
Published: (2017-04-01)

Temporal trends in healthcare resource utilization and costs following acute myocardial infarction
by: Arthur Shiyovich, et al.
Published: (2020-02-01)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Stylianos Petousis, et al.
Published: (2022-07-01)

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
by: Kreutz RP, et al.
Published: (2016-06-01)

Ticagrelor and omeprazole: A desirable combination in post MI patients?
by: Dimitrios Alexopoulos
Published: (2020-09-01)

Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01)

Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes
by: Side Gao, et al.
Published: (2021-12-01)

Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI
by: Fucheng Zhang, et al.
Published: (2020-09-01)

Proteção da recuperação funcional do miocárdio pelo omeprazol após isquemia-reperfusão em corações isolados de ratos Myocardium functional recovery protection by omeprazole after ischemia-reperfusion in isolated rat hearts
by: Otoni Moreira Gomes, et al.
Published: (2010-09-01)

Comparison between preoperative loading dose of ticagrelor versus clopidogrel on myocardial perfusion in type ii diabetic patients presenting with anterior wall myocardial infarction
by: Emad Effat Fakhry, et al.
Published: (2021-01-01)

Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
by: Pejman Khosravi, et al.
Published: (2010-01-01)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Bin YANG, et al.
Published: (2018-07-01)